NCT04131673Withdrawn
MS and NMOSD in African-Americans
MS and NMOSD in African-Americans: a Prospective Data Collection Protocol Using REDCap
Source: ClinicalTrials.gov · Last updated 14 Nov 2022
Reason given: IRB closed
Brief summary (registry, in English)
This is a prospective study that aims to collect and review neuromyelitis optica spectrum disorder (NMOSD) data from African American patients with a known diagnosis of multiple sclerosis (MS). It is an investigational study, prospective in nature. No randomization of patients will be done. Information collected includes: Age, gender, age at diagnosis, MRI data (access to images), clinical presentation, findings on clinical examination, lab (blood and evoked potentials) and LP test results, eye exam findings if any and treatment, if started. Additional details may include other NEUROLOGICAL diseases which are also diagnosed (if any).
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 14 Oct 2019
- Start date
- 5 Jul 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Jagannadha R Avasarala
- NCT number
- NCT04131673
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- between the ages of 18 and 80
- are African-American
- have a diagnosis of MS and later diagnosis of NMOSD
- have been seen at the University of Kentucky's Kentucky Neuroscience Institute
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kentucky | Lexington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.